Bio-Rad Laboratories (BIO) Cash & Current Investments (2009 - 2026)
Bio-Rad Laboratories (BIO) posted quarterly Cash & Current Investments of $1.6 billion for Q1 2026, down 5.76% year-over-year from $1.7 billion in Q1 2025, and up 1.56% quarter-over-quarter from $1.5 billion in Q4 2025.
Bio-Rad Laboratories (BIO) Cash & Current Investments (2009 - 2026) Analysis & Trends
Bio-Rad Laboratories (BIO) has reported Cash & Current Investments for 18 consecutive years, with $1.6 billion the latest figure, recorded in Q1 2026.
- In Q1 2026, Cash & Current Investments fell 5.76% year-over-year to $1.6 billion; the TTM figure through Mar 2026 stood at $1.6 billion (down 5.76% YoY), while the FY2025 annual figure was $1.5 billion, down 7.44% from the prior year.
- Cash & Current Investments rose to $1.6 billion in Q1 2026 per BIO's latest filing, from $1.5 billion in the prior quarter.
- Across five years, Cash & Current Investments topped out at $2.0 billion in Q2 2022 and bottomed at $412.5 million in Q2 2024.
- Historically, Cash & Current Investments has averaged $1.4 billion across 5 years, with a median of $1.6 billion in 2023.
- Annual changes were most pronounced in 2024 — Cash & Current Investments plunged 76.06% — and 2025, when it soared 278.34%.
- Bio-Rad Laboratories' Cash & Current Investments stood at $1.8 billion in 2022, then decreased by 10.25% to $1.6 billion in 2023, then climbed by 3.57% to $1.7 billion in 2024, then retreated by 7.44% to $1.5 billion in 2025, then increased by 1.56% to $1.6 billion in 2026.
- Business Quant data shows BIO's Cash & Current Investments at $1.6 billion in Q1 2026, $1.5 billion in Q4 2025, and $1.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.46 Bn | 193.86 Bn | 7.27 Bn | 5.60 Bn |
| 2 | Stryker | 127.41 Bn | 123.93 Bn | 4.50 Bn | 3.48 Bn |
| 3 | Medtronic | 118.87 Bn | 109.65 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 73.47 Bn | 72.93 Bn | 3.85 Bn | 539.00 Mn |
| 5 | Edwards Lifesciences | 51.95 Bn | 47.69 Bn | 1.35 Bn | 4.25 Bn |
| 6 | Dexcom | 34.30 Bn | 32.35 Bn | 830.00 Mn | 1.95 Bn |
| 7 | GE HealthCare Technologies | 33.76 Bn | 31.65 Bn | 2.18 Bn | 2.11 Bn |
| 8 | Koninklijke Philips | 26.35 Bn | 23.02 Bn | 4.55 Bn | 3.32 Bn |
| 9 | Steris | 23.04 Bn | 22.55 Bn | 684.20 Mn | 482.30 Mn |
| 10 | Bio-Rad Laboratories | 10.10 Bn | 8.49 Bn | 345.80 Mn | 1.62 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.62 Bn |
| Mar 31, 2026 | 1.56 Bn |
| Dec 31, 2025 | 1.54 Bn |
| Sep 30, 2025 | 1.42 Bn |
| Jun 30, 2025 | 1.37 Bn |
| Mar 31, 2025 | 1.66 Bn |
| Dec 31, 2024 | 1.66 Bn |
| Sep 30, 2024 | 1.62 Bn |
| Jun 30, 2024 | 412.46 Mn |
| Mar 31, 2024 | 438.86 Mn |
| Dec 31, 2023 | 1.61 Bn |
| Sep 30, 2023 | 1.76 Bn |
| Jun 30, 2023 | 1.72 Bn |
| Mar 31, 2023 | 469.70 Mn |
| Dec 31, 2022 | 1.79 Bn |
| Sep 30, 2022 | 1.85 Bn |
| Jun 30, 2022 | 1.97 Bn |
| Mar 31, 2022 | 807.88 Mn |
| Dec 31, 2021 | 476.38 Mn |
| Sep 30, 2021 | 865.46 Mn |